TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/08 18:31 | 11/21/08 | ILI | Interleukin Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bender Lewis H | MA | O | CEO | P.m | 8 | 0.2566 | 0 | 30 | 74 | 71 | D | ||||||||||||||
11/20/08 20:52 | 11/18/08 | ILI | Interleukin Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bender Lewis H | MA | O | CEO | P.m | 12 | 0.4093 | 0 | 30 | 284 | 41 | D | ||||||||||||||
2/20/08 17:01 | 2/19/08 | ILI | Interleukin Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bender Lewis H | MA | O | CEO | P | 4 | 1.40 | 0 | 3 | New | 3 | D | ||||||||||||||
4/22/05 09:18 | 4/20/05 | EMIS | Emisphere Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Bender Lewis H | NY | O | SVP | M.d | 11 | 1.55 | 0 | 7 | 46 | 23 | D | ||||||||||||||
5/11/04 15:38 | 5/7/04 | EMIS | Emisphere Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Bender Lewis H | NY | O | SVP Busi | M.d | 20 | 4.00 | 0 | 5 | 58 | 14 | D | ||||||||||||||
5/11/04 15:38 | 5/7/04 | EMIS | Emisphere Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Bender Lewis H | NY | O | SVP Busi | S.d | -26 | 5.18 | 0 | -5 | -27 | 14 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |